Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy

NCT06664541 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

NCT NCT06664541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06664541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy
Lead sponsor
Georgetown University
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 1, 2024
Completion date
December 1, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease, transfusion dependent beta thalassemia